BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10544377)

  • 1. [Development of Escherichia coli strands resistant to quinolones in stools of patients with liver cirrhosis submitted to selective bowel decontamination].
    Aparicio JR; Such J; Gutiérrez A; Pérez-Mateo M; Plaza J; Arroyo A
    Med Clin (Barc); 1999 Sep; 113(7):241-5. PubMed ID: 10544377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients.
    Ortiz J; Vila MC; Soriano G; Miñana J; Gana J; Mirelis B; Novella MT; Coll S; Sábat M; Andreu M; Prats G; Solá R; Guarner C
    Hepatology; 1999 Apr; 29(4):1064-9. PubMed ID: 10094947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of quinolone-resistant strains of Escherichia coli in stools of patients with cirrhosis undergoing norfloxacin prophylaxis: clinical consequences.
    Aparicio JR; Such J; Pascual S; Arroyo A; Plazas J; Girona E; Gutiérrez A; de Vera F; Palazón JM; Carnicer F; Pérez-Mateo M
    J Hepatol; 1999 Aug; 31(2):277-83. PubMed ID: 10453941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Norfloxacin decreases bacterial adherence of quinolone-resistant strains of Escherichia coli isolated from patients with cirrhosis.
    Gascón I; Pascual S; Plazas J; Sánchez J; Francés R; Más P; Zapater P; Pérez-Mateo M; Such J
    Aliment Pharmacol Ther; 2005 Mar; 21(6):701-7. PubMed ID: 15771756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.
    Novella M; Solà R; Soriano G; Andreu M; Gana J; Ortiz J; Coll S; Sàbat M; Vila MC; Guarner C; Vilardell F
    Hepatology; 1997 Mar; 25(3):532-6. PubMed ID: 9049193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of host and bacterial virulence factors in Escherichia coli spontaneous bacterial peritonitis.
    Cereto F; Herranz X; Moreno E; Andreu A; Vergara M; Fontanals D; Roget M; Simó M; González A; Prats G; Genescà J
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):924-9. PubMed ID: 18794608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.
    Fernández J; Ruiz del Arbol L; Gómez C; Durandez R; Serradilla R; Guarner C; Planas R; Arroyo V; Navasa M
    Gastroenterology; 2006 Oct; 131(4):1049-56; quiz 1285. PubMed ID: 17030175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of selective bowel decontamination with norfloxacin on spontaneous bacterial peritonitis, translocation, and survival in an animal model of cirrhosis.
    Runyon BA; Borzio M; Young S; Squier SU; Guarner C; Runyon MA
    Hepatology; 1995 Jun; 21(6):1719-24. PubMed ID: 7768517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of oral ciprofloxacin as selective intestinal decontaminant in cirrhosis.
    Borzio M; Salerno F; Saudelli M; Galvagno D; Piantoni L; Fragiacomo L
    Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):262-6. PubMed ID: 9646219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding.
    Sàbat M; Kolle L; Soriano G; Ortiz J; Pamplona J; Novella MT; Villanueva C; Sainz S; Torras J; Balanzó J; Guarner C
    Am J Gastroenterol; 1998 Dec; 93(12):2457-62. PubMed ID: 9860409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Spontaneous infection of ascitic fluid due to Salmonella typhimurium in a cirrhotic patient undergoing selective intestinal decontamination with norfloxacin].
    Lecleire S; Di Fiore F; Hervé S; Goria O; Savoye G; Colin R; Lerebours E
    Presse Med; 2003 Mar; 32(12):550-2. PubMed ID: 12714922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous bacterial peritonitis caused by quinolone-resistant Escherichia coli: could steroid therapy play a role?
    Cereto F; Genescà J; Smithson A; González A; Moreno G; del Valle Ortiz O; Esteban R; Guardia J
    Eur J Gastroenterol Hepatol; 2002 Jan; 14(1):81-3. PubMed ID: 11782580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norfloxacin and trimethoprim-sulfamethoxazole therapy have similar efficacy in prevention of spontaneous bacterial peritonitis.
    Lontos S; Gow PJ; Vaughan RB; Angus PW
    J Gastroenterol Hepatol; 2008 Feb; 23(2):252-5. PubMed ID: 17559367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination. A retrospective study of 229 spontaneous bacterial peritonitis episodes.
    Llovet JM; Rodríguez-Iglesias P; Moitinho E; Planas R; Bataller R; Navasa M; Menacho M; Pardo A; Castells A; Cabré E; Arroyo V; Gassull MA; Rodés J
    J Hepatol; 1997 Jan; 26(1):88-95. PubMed ID: 9148028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic background of Escherichia coli isolates from patients with spontaneous bacterial peritonitis: relationship with host factors and prognosis.
    Bert F; Panhard X; Johnson J; Lecuyer H; Moreau R; Le Grand J; Johnston B; Sinègre M; Valla D; Nicolas-Chanoine MH
    Clin Microbiol Infect; 2008 Nov; 14(11):1034-40. PubMed ID: 19040475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased invasive capacity of quinolone-resistant Escherichia coli in patients with urinary tract infections.
    Velasco M; Horcajada JP; Mensa J; Moreno-Martinez A; Vila J; Martinez JA; Ruiz J; Barranco M; Roig G; Soriano E
    Clin Infect Dis; 2001 Nov; 33(10):1682-6. PubMed ID: 11595990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of spontaneous Aeromonas bacterial peritonitis in cirrhotic patients: a matched case-control study.
    Choi JP; Lee SO; Kwon HH; Kwak YG; Choi SH; Lim SK; Kim MN; Jeong JY; Choi SH; Woo JH; Kim YS
    Clin Infect Dis; 2008 Jul; 47(1):66-72. PubMed ID: 18484880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escherichia coli capsular polysaccharide and spontaneous bacterial peritonitis in cirrhosis.
    Soriano G; Coll P; Guarner C; Such J; Sánchez F; Prats G; Vilardell F
    Hepatology; 1995 Mar; 21(3):668-73. PubMed ID: 7875665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The duration of the effect of norfloxacin on the fecal flora in cirrhosis patients].
    Soriano G; Guarner C; Tomás A; Anguera A; Mirelis B; Fernández C; Herrero M; Alonso C; Vilardell F
    Rev Esp Enferm Dig; 1992 May; 81(5):322-6. PubMed ID: 1616740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and clinical outcome of spontaneous bacterial peritonitis in hospitalized patients with liver cirrhosis: a prospective observational study in central part of Croatia.
    Gunjaca I; Francetić I
    Acta Clin Croat; 2010 Mar; 49(1):11-8. PubMed ID: 20635579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.